Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.38) per share.
Inari Medical Announces Results From The Fully Enrolled 800-patient US Cohort Of The FlowTriever FLASH Registry
Inari Medical, Inc. (NASDAQ:NARI) ("Inari") a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive